Chimeric antigen receptor T-cell therapy induces complete remission in a patient with concurrent CLL with CNS involvement and multiple sclerosis - PubMed
5 hours ago
- #CAR T-cell therapy
- #Multiple Sclerosis
- #Chronic Lymphocytic Leukemia
- CAR T-cell therapy targeting CD19 resulted in complete remission of CLL with CNS involvement.
- The therapy also led to significant improvement in multiple sclerosis disease burden.
- This case highlights the potential of CAR T-cell therapy in treating concurrent hematologic and autoimmune conditions.